Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062). [electronic resource]
Producer: 19990212Description: 719-25 p. digitalISSN:- 1078-0432
- Administration, Oral
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Bone Marrow -- pathology
- Carcinoma, Small Cell -- drug therapy
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Regression Analysis
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.